An introduction of JPMA, from our philosophy to our organizational framework and details of our specific activities.

• About JPMA
• President's Message
• Board of Directors
• Structure of JPMA
• Related Organizations
• Member Companies
• Access

JPMA's policies and guidelines.

• JPMA Industry Vision 2025
• JPMA Charter of Corporate Behavior
• Code of Practice
• Transparency Guideline
• Intellectual Property
• Global Health

"To expedite the launch of innovative medicines for the peoples in asia"

• 4^th APAC
• 3^rd APAC
• 2^nd APAC
• 1^st APAC

Shared Dreams of Better Health Across Borders, Across Time

• Sustainable Development Goals, SDGs
• Innovation
• Intellectual Property Rights
• Three Major Infectious Diseases and Neglected Tropical Diseases (NTDs)
• Non-Communicable Diseases (NCDs)
• Countermeasures against Counterfeit Medicines
• Antimicrobial resistance (AMR)
• Strengthening Measures on Emerging Infectious Diseases
• Capacity Building
• Universal Health Coverage
• Global Health Issues
• JPMA Position Statements

Reports and data sheets concerning the pharmaceutical industry and market.

• Japan Pharmanceutical Reference
• Environmental Report
• Holding the 2014 Life Science IP Forum

Overview of Japanese regulations

• Pharmaceutical Administration and Regulations in Japan(whole document)
• Pharmaceutical Administration and Regulations in Japan(individual chapters)